在严重喘中研究生物启动和药物坚持之间的关联:对链接数据的分析
Amy Shackleford1, Liam G Heaney2, P Jane McDowell2
1School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, United Kingdom.
概括
在严重喘患者中,生物药物并没有显著改变吸入性皮质类固醇/长效β2-激动剂的坚持性. 然而,对这些药物的良好坚持与治疗后更少的喘恶化有关.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 吸入性皮质类固醇 (ICS) /长效β2-激动剂 (LABA) 的坚持对于喘管理至关重要,但往往很差.
- 之前对生物治疗喘群体的ICS坚持的研究产生了不一致的发现,缺乏长期结果数据.
研究的目的:
- 评估生物治疗启动对ICS/LABA坚持的长期影响.
- 为了确定不理想的ICS/LABA坚持对接受生物治疗严重喘的患者临床结果的影响.
主要方法:
- 从2015年9月到2021年11月,对207名严重喘患者进行了回顾性队列研究.
- 药物占有率 (MPR) 从发行记录计算;良好的坚持被定义为MPR≥75%.
- 使用多变量模型分析生物启动前和后的坚持变化及其与临床结果的关联.
主要成果:
- 28.0%的患者在使用生物药物之前具有低于最佳的坚持,与更高的剥夺和部分呼出的氧化 (FeNO) 有关.
- 人口层面的坚持保持稳定,但个体的坚持有所不同; 33.3%的人在生物启动后一年的坚持不佳.
- 与不良的坚持相比,良好的坚持与进一步减少17.4%的恶化相关,而对症状或肺功能没有显著影响.
结论:
- 生物介绍对整体坚持的影响很小,但导致了显著的个体患者变化.
- 持续良好遵守ICS/LABA治疗与生物治疗严重喘患者的恶化率降低有关.
更多相关视频
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
22.6K
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10.5K
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
394
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
394
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20Asthma: Pathogenesis and Management
607
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
607
01:23Inhaled Medications
398
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
398
01:30Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
398
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
398